The Misuse of Drugs Act 1971 (Amendment) Order 2022

Amendments to the Misuse of Drugs Act 1971

This adran has no associated Memorandwm Esboniadol

2.—(1) The following amendments are made to Schedule 2 to the Misuse of Drugs Act 1971.

(2) In paragraph 1(a) of Part 2 (which specifies the drugs which are subject to control under that Act as Class B drugs)(1)—

(a)after “N-Benzyl-ethylphenidate.” insert “1,4-Butanediol.”;

(b)after “Ethylphenidate.” insert “Gamma-butyrolactone.”;

(c)after “Glutethimide.” insert “4-Hydroxy-n-butyric acid.”.

(3) In paragraph 1(a) of Part 3 (which specifies the drugs which are subject to control under that Act as Class C drugs)(2)—

(a)omit “Gamma-butyrolactone”;

(b)omit “4-Hydroxy-n-butyric acid”.

(4) In paragraph 1(b) of Part 3(3) omit “1,4-Butanediol.”.

(1)

Relevant amending instruments are S.I. 1985/1995, 2017/634.

(2)

Relevant amending instruments are S.I. 2003/1243, 2009/3209.

(3)

Amended by S.I. 2009/3209; there are other amending instruments but none is relevant.